We are live on
!
Find out more
ADIM
Alpha DNA Investment Management Portfolio holdings
AUM
$8.98M
1-Year Est. Return
26.05%
This Fund
S&P 500
This Quarter
Est. Return
+10.42%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$300M
AUM Growth
-$38.9M
(-11%)
Cap. Flow
-$58.8M
Cap. Flow
% of AUM
-19.63%
Top 10 Holdings %
Top 10 Hldgs %
51.53%
Holding
226
New
79
Increased
25
Reduced
41
Closed
79
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPG Industries
PPG
|
+$3M |
| 2 |
TE Connectivity
TEL
|
+$2.05M |
| 3 |
NextEra Energy
NEE
|
+$1.96M |
| 4 |
Coca-Cola
KO
|
+$1.89M |
| 5 |
Merck
MRK
|
+$1.79M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$2.79M |
| 2 |
Mondelez International
MDLZ
|
+$2.26M |
| 3 |
Walmart Inc
WMT
|
+$2.23M |
| 4 |
Becton Dickinson
BDX
|
+$2.05M |
| 5 |
Blackrock
BLK
|
+$1.78M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.46% |
| 2 | Healthcare | 12.06% |
| 3 | Financials | 9.27% |
| 4 | Industrials | 7.3% |
| 5 | Consumer Staples | 4.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Fiverr
FVRR
$315M
| $742K | 0.25% |
+28,536
| New | +$860K |
|
127
ANI Pharmaceuticals
ANIP
$1.71B
| $739K | 0.25% |
+13,720
| New | +$608K |
|
128
City Holding Co
CHCO
$2.06B
| $737K | 0.25% |
8,186
-3,573
| -30% | -$324K |
|
129
Sixth Street Specialty
TSLX
$1.78B
| $730K | 0.24% |
+39,061
| New | +$712K |
|
130
Lemonade
LMND
$4.09B
| $726K | 0.24% |
+43,108
| New | +$674K |
|
131
uniQure
QURE
$3.12B
| $720K | 0.24% |
+62,825
| New | +$1.19M |
|
132
NeoGenomics
NEO
$2.12B
| $715K | 0.24% |
+44,465
| New | +$733K |
|
133
Harmony Biosciences
HRMY
$2.3B
| $712K | 0.24% |
+20,242
| New | +$699K |
|
134
Fate Therapeutics
FATE
$319M
| $703K | 0.23% |
+147,651
| New | +$815K |
|
135
Alkermes
ALKS
$8.26B
| $694K | 0.23% |
+22,186
| New | +$672K |
|
136
Legend Biotech
LEGN
$4.22B
| $680K | 0.23% |
+9,844
| New | +$643K |
|
137
Seres Therapeutics
MCRB
$46.6M
| $664K | 0.22% |
+6,927
| New | +$754K |
|
|
SENT
138
DELISTED
AdvisorShares Alpha DNA Equity Sentiment ETF
SENT
| $437K | 0.15% |
18,110
-49,622
| -73% | -$1.13M |
|
139
Royce Value Trust
RVT
$2.3B
| $337K | 0.11% |
24,400
| – | – |
|
140
lululemon athletica
LULU
$14.3B
| $268K | 0.09% |
+707
| New | +$261K |
|
141
Broadcom
AVGO
$1.98T
| $229K | 0.08% |
+2,640
| New | +$188K |
|
|
BLD
142
DELISTED
TopBuild
BLD
| $219K | 0.07% |
+825
| New | +$181K |
|
|
WCC
143
WESCO International
WCC
$17.8B
| $219K | 0.07% |
+1,221
| New | +$178K |
|
|
DFS
144
DELISTED
Discover Financial Services
DFS
| $214K | 0.07% |
+1,831
| New | +$192K |
|
145
Microchip Technology
MCHP
$44B
| $213K | 0.07% |
2,379
-16,617
| -87% | -$1.31M |
|
146
State Street SPDR S&P 500 ETF Trust
SPY
$807B
| $190K | 0.06% |
429
+10
| +2% | +$4.2K |
|
147
iShares Russell 2000 ETF
IWM
$81.8B
| $187 | ﹤0.01% |
1
| – | – |
|
148
Airbnb
ABNB
$111B
| – | – |
-11,236
| Closed | -$1.4M |
|
149
Analog Devices
ADI
$188B
| – | – |
-7,196
| Closed | -$1.42M |
|
150
Allegiant Air
ALGT
$2.37B
| – | – |
-11,867
| Closed | -$1.09M |
|
Similar funds
CAWM
AI
PC
CP
AVM
CSD
NP
BPWM
Alpha DNA Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, Alpha DNA Investment Management held 226 positions worth $300M, down 11% from $339M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Alpha DNA Investment Management withdrew a net $58.8M in Q2 2023, closing 79 positions and reducing 41 holdings. Its most notable exit was Becton Dickinson, an estimated $2.05M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Alpha DNA Investment Management opened a new position in TE Connectivity worth $2.27M.
- Alpha DNA Investment Management's largest Q2 2023 buy was TE Connectivity: 16,223 shares worth $2.27M.
- Alpha DNA Investment Management added most to PPG Industries in Q2 2023, an estimated $3M increase.
- Alpha DNA Investment Management's biggest Q2 2023 reduction was PepsiCo, cutting an estimated $2.79M.
- Alpha DNA Investment Management fully exited Becton Dickinson in Q2 2023, selling an estimated $2.05M.
- Alpha DNA Investment Management's ten largest holdings make up 52% of its $300M portfolio in Q2 2023.
- Alpha DNA Investment Management opened 79 new positions and closed 79 in Q2 2023.
- Alpha DNA Investment Management's portfolio value fell 11% quarter-over-quarter to $300M.
Based on Alpha DNA Investment Management's 13F filing for Q2 2023, filed 31 Jul 2023.